Microneedle Drug Delivery Systems Global Market Report 2024

A microneedle drug delivery system is a device that incorporates hundreds of microneedles on a patch to administer a precise amount of drug during treatment.

The main types of technologies used in microneedle drug delivery systems include solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, and others. In the solid microneedle method, peptides are dried onto the tips of a microneedle array, utilizing a coating of potent chemicals. These solid microneedles typically measure between 250 micrometers to 700 micrometers in length and are presented in patch form, allowing for storage at room temperature. Microneedle drug delivery systems find application in drug delivery, vaccine administration, and other therapeutic uses. They are employed in various settings such as diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgical centers, and other medical facilities.

The microneedles drug delivery systems market research report is one of a series of new reports that provides microneedle drug delivery systems market statistics, including microneedle drug delivery systems industry global market size, regional shares, competitors with a microneedle drug delivery systems market share, detailed microneedles drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle drug delivery systems industry. This microneedle drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle drug delivery systems market size has grown rapidly in recent years. It will grow from $4.32 billion in 2023 to $5.13 billion in 2024 at a compound annual growth rate (CAGR) of 18.7%. The growth observed in the historical period can be attributed to several factors, including the appeal of pain-free drug delivery, improved patient compliance due to the convenience of microneedle systems, their utility in the management of chronic diseases, and applications in cosmetic and aesthetic procedures.

The microneedle drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $9.82 billion in 2028 at a compound annual growth rate (CAGR) of 17.6%. The anticipated growth in the forecast period can be attributed to various factors, including the increasing applications in cosmetic and aesthetic procedures, the emergence of new therapeutic uses, expanded utilization in pediatric and geriatric populations, global health initiatives promoting innovative drug delivery methods, and the rise of point-of-care testing. Key trends expected in the forecast period encompass the development of smart microneedles, advancements in material science improving microneedle design and performance, innovations in wearable technology complementing microneedle applications, the use of biodegradable materials for sustainable drug delivery, and the integration of microneedles in continuous glucose monitoring systems.

The anticipated rise in research activities and the demand for vaccination processes is poised to propel the growth of the microneedle drug delivery systems market. Microneedles are considered an alternative method for vaccine injection, offering a painless experience for recipients. Initially developed for flu and measles vaccines, microneedle patches are now increasingly utilized for the delivery of COVID-19 vaccines as well. A Bloomberg report highlights that over 3.98 billion vaccine doses have been administered across 180 countries as of July 2021. The heightened demand from governmental and health research and development bodies for microneedle drug delivery technology is a significant factor driving the market's growth.

The escalating prevalence of obesity is expected to drive the future growth of the microneedle drug delivery systems market. Obesity, characterized by an excess of body fat that can negatively impact health, sees the use of microneedle drug delivery systems for the convenient and painless delivery of medications. In England, according to the Government Digital Service, the projected obesity rate among individuals aged 18 and older increased to 25.9% in 2021–2022, marking a 25.2% rise. This growing prevalence of obesity contributes to the expanding market for microneedle drug delivery systems.

Major players in the microneedle drug delivery systems market are concentrating on product innovation, exemplified by products like the MicronJet 600, to offer reliable services to customers. The MicronJet 600 serves as a microneedle drug delivery system for vaccines, drugs, peptides, and dermal fillers. NanoPass Technologies Ltd., a US-based company specializing in painless intradermal delivery solutions, introduced the MicronJet 600 in November 2021. This microneedle-based device secured Food and Drug Administration (FDA) clearance as the first true (< 1 mm) microneedle for intradermal drug delivery below the skin's surface.

Strategic partnerships are a key approach adopted by major companies in the microneedle drug delivery systems market to enhance profitability. For instance, in October 2021, The Tapemark, a US-based pharmaceutical company manufacturing transdermal drug delivery systems with microneedles, collaborated with 10X Technology Inc. The partnership aims to introduce new solutions to the pharmaceutical transdermal space, specifically commercializing MicroDerm, a microneedle-based device for intradermal drug delivery. 10X Technology Inc., a US-based microstructured solution company, specializes in manufacturing dissolvable microneedles.

In February 2021, the Terasaki Institute, a US-based research organization, formed a partnership with PharmaTher to develop a microneedle patch for delivering psychedelic pharmaceuticals, aiming for more efficient and effective delivery methods. PharmaTher, a Canada-based pharmaceutical company, specializes in providing microneedle drug delivery systems.

Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.

North America was the largest region in the microneedle drug delivery systems market in 2023. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the microneedle drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The microneedle drug delivery systems market consists of sales of hydrogel microneedles and dissolvable microneedle. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.